A study reveals racial and ethnic disparities in access to Novo Nordisk's diabetes and weight loss drugs among U.S. military veterans. Black, Asian, and Native American patients are less likely to ...

U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

Novo Nordisk's U.S.-traded shares were down 3% in morning trading Wednesday. Investopedia requires writers to use primary sources to support their work. These include white papers, government data ...

SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Novo Nordisk is urging the U.S. Food and Drug Administration ... your retirement nest egg in 2025 — no matter who takes the White Houses Protect your retirement savings with these 5 essential ...

Pharmaceutical giant Novo Nordisk (NVO) plans to use Denmark's first ... use primary sources to support their work. These include white papers, government data, original reporting, and interviews ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Eli Lilly reported third-quarter earnings and revenue below Wall Street expectations, reducing its full-year adjusted profit outlook. The pharmaceutical company cited weaker sales of its weight loss ...

As President-elect Donald Trump's transition team vets candidates for key healthcare positions, pharmaceutical industry ...

Presidential election could be decided in the fast-growing suburbs of the Tar Heel State — where Democrats are working for a ...

Only three drugs – Novo Nordisk’s Wegovy and Saxenda ... for legitimate patients and encouraging the rise of a dangerous black market for counterfeit drugs. The sudden and overwhelming ...

But she highlights one idea: in a report funded by semaglutide-maker Novo Nordisk that she co-authored, her team found that ...